IGF-I in early-stage Alzheimer's diesease: a potential therapeutic target?

Author： Duron Emmanuelle   Epelbaum Jacques   Hanon Olivier  

Publisher： Informa Healthcare

ISSN： 1744-6651

Source： Expert Review of Endocrinology and Metabolism, Vol.8, Iss.2, 2013-03, pp. : 97-99

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Validation of the 7-Minute Screen for the Detection of Early-Stage Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 25, Iss. 3, 2008-02 ,pp. : 248-255

Karger

Access to resources Recommend Favorite

Utility of Free IGF-I Measurements

By Frystyk Jan  

Pituitary, Vol. 10, Iss. 2, 2007-06 ,pp. : 181-187

Springer Publishing Company

Access to resources Recommend Favorite

Sacred Relationships, Strengthened by Community, Can Help People with Mild or Early-Stage Alzheimer's

By  

Generations, Vol. 38, Iss. 1, 2014-04 ,pp. : 61-67

American Society on Aging

Access to resources Recommend Favorite

Is the Vasculature a Potential Therapeutic Target in Arthritis?

By  

Current Rheumatology Reviews, Vol. 2, Iss. 2, 2006-05 ,pp. : 151-158

Bentham Science Publishers

Access to resources Recommend Favorite

IGF-I measurements in the monitoring of GH therapy

By Higham Claire   Jostel Andreas   Trainer Peter  

Pituitary, Vol. 10, Iss. 2, 2007-06 ,pp. : 159-163

Springer Publishing Company

Access to resources Recommend Favorite